Form4insider filings, from the source

SEC Form 4 · accession 0001237899-15-000046

REGENERON PHARMACEUTICALS, INC. · REGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 6, 2015
Accepted (ET)
Aug 7, 2015 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 6, 2015M5,000$57.11A13,912D
Common StockF1Aug 6, 2015S300$582.15D13,612D
Common StockF2Aug 6, 2015S400$583.43D13,212D
Common StockF3Aug 6, 2015S800$584.52D12,412D
Common StockF4Aug 6, 2015S800$585.35D11,612D
Common StockF5Aug 6, 2015S200$586.49D11,412D
Common StockF6Aug 6, 2015S400$587.55D11,012D
Common StockF7Aug 6, 2015S400$588.33D10,612D
Common StockF8Aug 6, 2015S400$589.73D10,212D
Common StockF9Aug 6, 2015S900$590.37D9,312D
Common StockF10Aug 6, 2015S200$591.39D9,112D
Common StockF11Aug 6, 2015S138$592.53D8,974D
Common StockAug 6, 2015S62$593.00D8,912D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F12$57.11Aug 6, 2015M5,000D—Jan 3, 2022Common Stock5,0000D

Explanation of responses